Overview

Understanding Experimentally Induced Hot Flushes

Status:
Completed
Trial end date:
2007-09-02
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the impact of hot flushes on sleep, mood, and well-being. The investigators will cause hot flushes by giving study participants the hormone medication, leuprolide (Lupron), which is a manufactured (artificial) hormone that makes the body think that it has reached menopause temporarily. Most women begin to have hot flushes within 4 weeks after taking leuprolide and resume menses 3 months later. The investigators will administer questionnaires to evaluate changes in sleep and mood over the course of the study.
Phase:
Phase 4
Details
Lead Sponsor:
Hadine Joffe, MD
Massachusetts General Hospital
Collaborator:
Endocrine Research Society
Treatments:
Leuprolide